EnCor Biotechnology is Biotechnology in United States that focus on chicken polyclonal antibodies business. Founded in 2002. They cover business area such as owner, operator, antibody production, development, imaging, commercialization, unique, well-characterize antibody reagent, mouse monoclonal, chicken polyclonal antibody, researcher, enzyme-link immunosorbent, academic, bio-pharmaceutical, and clinical research.
2002
( 22 years old in 2024 )
Chicken Polyclonal Antibodies
-
4949 South-West 41st Boulevard
Suite 40
Gainesville, FL 32608
United States
Private
owneroperatorantibody productiondevelopmentimagingcommercializationunique, well-characterize antibody reagentmouse monoclonalchicken polyclonal antibodyresearcherenzyme-link immunosorbentacademic, bio-pharmaceutical, and clinical research
* We use standard office opening hours in near EnCor Biotechnology's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
EnCor Biotechnology is Biotechnology business from United States that founded in 2002 (22 years old in 2024), EnCor Biotechnology business is focusing on Chicken Polyclonal Antibodies.
EnCor Biotechnology headquarter office and corporate office address is located in 4949 South-West 41st Boulevard Suite 40 Gainesville, FL 32608 United States.
EnCor Biotechnology was founded in United States.
In 2024, EnCor Biotechnology is currently focus on chicken polyclonal antibodies sector.
Above is snippet of Google Trends for "chicken polyclonal antibodies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with EnCor Biotechnology, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
